Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001493152-20-003663

Options or other derivatives

  • Director acquired 66,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Salzmann Peter · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-03-06 Grant or award : show line 1 in the form Stock Option(right to buy) +66,600 $4.53 2030-03-06 66,600 66,600 D
Loading xslF345X03/ownership.xml…